Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab

  • ECULIZUMAB IN THE MANAGEMENT OF HYPERHEMOLYSIS
  • Mark Boonyasampant, Ilene C. Weitz, Brian Kay, Chaiyaporn Boonchalermvichian, Howard A. Liebman, Ira A. Shulman
  • Transfusion, May 2015, Wiley
  • DOI: 10.1111/trf.13144

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/trf.13144

In partnership with:

Link to Wiley showcase